Objective: To evaluate the risk of elective delivery of hospitalized patients with isolated mild preeclampsia with mature fetal lung profile compared with a cohort of patients who had preeclampsia with indicated delivery matched for gestational age.
Introduction
Preeclampsia is a common disorder complicating 6 to 8% of pregnancies in the United States. 1 Management recommendation is based on severity of the disease and the gestational age of the pregnancy. The earlier the pregnancy, the more aggressive we are with expectant management to optimize neonatal outcome. 2 Management of mild preeclampsia is controversial. Term patients should be delivered. Patients less than 34 weeks should be treated expectantly. 3 The pregnancies in the late preterm gestation (34 to 37 weeks) are controversial. Many expectantly manage these patients, whereas some opt to deliver the patients. 2, 4 Our group has been offering amniocentesis for fetal lung assessment, and if the fetal lungs are mature, give present delivery as an option.
The purpose of this study is to evaluate our outcomes of late preterm preeclamptic pregnancies delivered after mature fetal lung assessment and compare them to a group of indicated or spontaneous preeclamptic deliveries matched for gestational age.
Methods
Patients diagnosed with mild preeclampsia, as defined by the American College of Obstetricians and Gynecologists, and requiring hospitalization were offered amniocentesis for fetal lung maturity. The patients were managed by the same two Perinatologists at two tertiary centers in North Louisiana (LSU Health Sciences Center-Shreveport and Willis Knighton Medical Center). If the patient consented, an ultrasound-guided amniocentesis was performed. The fluid was initially sent for TDx-Fetal lung maturity assays (FLM-II), which was performed in-house (Abbott Laboratories in Abbott Park, IL, USA). If immature (FLM<55), the fluid was then sent for a lecithin/sphingomyelin (L/S) ratio. If maturity was established (FLM X55 or L/S ratio X2.0), then these patients were offered delivery. Patients were excluded if they had received corticosteroids. The study took place over a 4-year period, and the analysis was IRB approved.
To be eligible for our analysis, the patients must have a well-dated singleton pregnancy, have mild preeclampsia requiring hospitalization, have good obstetrical dates 5 (prenatal care before 20 weeks with ultrasound confirmation of dates) and have no other obstetrical (growth restriction, oligohydramnios) or medical complications such as diabetes or chronic hypertension. Mild preeclampsia was defined as a blood pressure of 140/90 with proteinuria of at least 300 mg on a 24-h urine and the absence of any features of severe disease. All mild preeclampsia was managed as an in-patient, and all had a 24-h urine.
A well-dated 5 control group that had preeclampsia with indicated or spontaneous deliveries were then identified controlling for gestational age. The control group could have severe preeclampsia but no HELLP syndrome, oligohydramnios or growth restriction. These patients did not have any medical complications either. Maternal and neonatal charts were obtained to evaluate the outcome of the pregnancies and neonates.
Outcomes of interest included neonatal complications such as respiratory distress syndrome (RDS), special care nursery admission and neonatal length of stay. RDS was defined as radiographic evidence of a fine reticular pattern on chest radiography with clinical evidence of respiratory difficulty such as grunting, retraction and/or tachypnea and the need for oxygen. Other neonatal, maternal and pregnancy characteristics were also compared. Statistical analysis included the use of Fishers exact test, w 2 analysis and Mann-Whitney U-test. A P-value of <0.05 was considered significant.
Results
Over a 4-year period, 51 patients had mild preeclampsia, met the study criteria and were delivered for mature fetal lung profile. These were compared with 51 control patients who met study criteria, with 32 of these patients having severe preeclampsia as their indication for delivery. Maternal and pregnancy characteristics are presented in Table 1 . The hospital days before admission and the total hospital days were different between the groups. More days were noted in the mild preeclampsia group, as one would expect, due to their in-hospital status.
Sixteen neonates were delivered for mature FLM and 35 for mature L/S ratios. Five infants (9.8%) in the mature group developed RDS. All neonates that developed RDS had negative FLM and mature L/S ratios. The rate of RDS was no different than the control group. Other neonatal outcomes are presented in Table 2 . A high percentage of neonates in both groups were admitted to the neonatal intensive care unit (31 and 41%, respectively). The neonatal intensive care unit stay was longer in the control group.
Discussion
Preeclampsia continues to be a major cause of maternal and perinatal morbidity and mortality. Few changes in the management protocols for mild preeclampsia have occurred in modern obstetrics. The American College of Obstetricians and Gynecologists recommend expectant management of mild preeclampsia until 37 weeks and then delivery unless other complications exist. 3 Despite this, many obstetricians are expediting delivery either by amniocentesis and delivery for documented fetal lung maturity or just delivering pregnancies that are complicated by mild preeclampsia. 4 Our group started offering amniocentesis with elective delivery after several bad outcomes occurred to patients with expectant management of mild disease during these gestational ages. Risk to neither the mother nor the fetus has been established with expectant management during these gestational ages. Further research in this area is needed.
The incidence of RDS morbidity in this series is concerning. Wigton et al. 6 found very little morbidity from RDS if patients were delivered with mature lung profile from these gestational ages. Ghidini et al., 7 however, found worse results than we did using the L/S ratio. They found 26.7% of their mature L/S ratios were complicated by RDS regardless of the gestational age. The results of Ghidini et al. and our study are concerning.
Delivery of mild preeclampsia during this late preterm gestational age is being performed without data to support this intervention. Late preterm delivery continues to increase in the United States at an alarming rate. Delivery at these gestational ages has elevated to such a concern that the National Institute of Child Health and Human Development had a workshop to address this problem. In this workshop, one of the recommendations was to evaluate the disease-specific protocols and evaluate the outcome at these gestational ages. 8 What part preeclampsia plays in this increase is unknown. 9 This manuscript attempts to address an important issue in the management of mild preeclampsia.
Our results are very concerning. Approximately 10% of our 'mature' fetuses developed RDS, and 31% were admitted to the neonatal intensive care unit. This report is supported by a recent report by Habli et al. 10 who found higher complications in neonates born to patients with preeclampsia when matched for gestational age than those delivered with other complications. Others have shown that infants born to preeclamptics have a higher rate of RDS.
11-13
The infants who developed RDS in our series all had negative TDx and 'positive' L/S ratio levels. Mixed results have been found in the literature when evaluating the L/S ratios ability to predict mature fetal lungs. Why this test in our series and the ones in Ghidini et al. 7 series did not predict RDS is unknown. The test is being performed less frequently now, most likely due to the availability of rapid test such as TDx and lamellar body count evaluation. Many reference laboratories do not perform this test with the same quality as first described by Gluck et al. 14 This test requires a significant amount of time to perform as well as special expertise to produce accurate result. The quality of analysis provided by the laboratories is unknown but could explain the clinical results we observed.
Our study has limitations inherent with any retrospective analysis. The authors believed to have an appropriate control group, the patients must have preeclampsia due to the known effect it has on lung maturity. Preeclampsia has been shown to delay lung maturation in several studies evaluated in different ways. 11 We controlled for as many confounders as possible including medical complications, such as chronic hypertension and diabetes, as well as obstetrical complications such as growth restriction and oligohydramnios. None of the patients in our study were diagnosed with any of these complications to be included in the study. To our knowledge, this is the first study evaluating this question. However, our study is under-powered, and the best method to answer the question would be to perform a prospective randomized trial.
Why deliver these patients, one may ask. There is a definite risk of progression to severe disease with potential increase in both maternal and neonatal complications. 15 Whether this 'risk' warrants this aggressive management is unknown. We believe that if an amniocentesis to assess lung maturity were to be performed, TDx or evaluation for phosphatidylglycerol would be a more appropriate evaluation of fetal lung maturation than the use of the L/S ratio. We do not believe, as some do, that elective delivery should just be undertaken without an indication or solid evidence of lung maturation.
In conclusion, delivery of mild preeclamptic patients in the late preterm gestational ages carries risks. These risks include a 10% incidence of RDS if relying on the L/S ratio. Prospective studies are needed to answer this important clinical question. At present, a large prospective study is underway in Europe that will help answer part of this question, because it includes elective delivery of mild preeclamptics starting at 36 weeks gestational age. 16 
